Publications / Scientific Publications /

Initial Clinical Results of a New Telescopic IOL Implanted in Patients With Dry AgeRelated Macular Degeneration


PURPOSE: To evaluate the safety and efficacy of the iol­AMD technology (London Eye Hospital Pharma, London, UK), which includes two injectable, hydrophobic acrylic intraocular lenses (IOLs) in a pilot study of patients di­agnosed as having cataract and dry age-related macular degeneration.

METHODS: The cataract surgery and IOL implantation were performed after a preoperative evaluation using the iolAMD simulator in eyes with bilateral intermediate dry age-related macular degeneration. Outcomes were intraoperative and postoperative complications, subjec­tive and objective visual acuity improvement, visual field changes, and postoperative diplopia.

RESULTS: Three eyes of 2 patients were evaluated. The surgeries were uneventful. All eyes gained mon­ocular reading vision at the 1-week postoperative visit. One patient with monocular implantation recognized diplopia for distance vision. Preoperative corrected dis­tance visual acuity ranged from 20/800 to 20/125 and corrected near visual acuity was 20/800 or less. Two months after surgery, corrected distance and near visual acuities increased to levels between 20/40 and 20/25 (uncorrected distance visual acuity was 20/60 to 20/32; uncorrected near visual acuity was 20/200 to 20/25).

CONCLUSIONS: These early results showed that the iolAMD simulator is a promising technology improving near and distance visual acuity in eyes with intermedi­ate dry macular degeneration. The prismatic IOL effect did not lead to diplopia when implanted bilaterally. The surgery was safely performed.


Copyright © SLACK Incorporated
If you like it, please share it...Tweet about this on Twitter0Share on Facebook0